• Divalproex sodium Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Hydrolytically Shielded Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the intensely hygroscopic active ingredient.

    Active IngredientStrengthPrimary Clinical Function
    Divalproex Sodium USP/Ph.Eur.250 mg (DR / ER)The Titration & Pediatric Standard: The definitive unit utilized for careful initial dose titration in adult bipolar patients or weight-based dosing for pediatric epilepsy.
    Divalproex Sodium USP/Ph.Eur.500 mg (DR / ER)The Neurology Macrodose: Massive therapeutic payload utilized for the aggressive, sustained suppression of chronic complex partial seizures and acute bipolar mania.
    Excipients (Enteric DR Formulation)Microcrystalline Cellulose / Croscarmellose Sodium / Povidone / Methacrylic Acid Copolymer (Eudragit) / Triethyl Citrate / Titanium DioxideDiluent / Superdisintegrant / Binder / Enteric Polymer / Plasticizer / Opaque Film (Engineered specifically utilizing advanced fluid-bed enteric coating to completely shield the highly corrosive valproate compound from the stomach, ensuring the pill only dissolves in the alkaline environment of the small intestine to prevent severe gastric bleeding and vomiting)

    *Pack Sizes: 10×10 Alu-Alu Blisters or Heavy-Gauge HDPE Bottles (Optimized specifically for strict chronic neurology and psychiatry dispensing regimens).

  • Mesalazine Prolonged release Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, pH-Targeted PR Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly oxidative 5-ASA molecule.

    Active IngredientStrengthPrimary Clinical Function
    Mesalazine (5-ASA) USP/Ph.Eur.400 mg (PR)Initiation / Titration Standard: Base therapeutic unit for mild presentations or pediatric titration in pediatric gastroenterology.
    Mesalazine (5-ASA) USP/Ph.Eur.800 mg / 1200 mg (PR)Global Gastroenterology Standard: High-efficacy adult maintenance doses designed to improve patient compliance by drastically reducing the daily pill burden.
    ExcipientsMethacrylic Acid Copolymer Type B & C (Eudragit L/S) / Hypromellose / Triethyl Citrate / Iron Oxide Colors / TalcEnteric & Prolonged-Release Polymers / Plasticizer / Glidant (Engineered specifically to form an impenetrable, acid-resistant shield that strictly delays drug release until reaching the high-pH environment of the lower gastrointestinal tract)